OR WAIT 15 SECS
January 21, 2021
There is considerable variation in the regulatory approach to medical cannabis between European countries. Yet, despite the complexity, there are clear routes to market, reports Peter Kohut.
January 12, 2021
On December 24, 2020, the UK finally agreed a Trade and Cooperation Agreement (TCA) with the EU. Cliodhna McDonough offers some initial thoughts on the implications of the TCA on the life sciences sector.
EU tasked with translating bold declarations into reality.
December 11, 2020
Must find common ground between digitalization and protection laws.
November 16, 2020
Must maintain trust in face of customary, non-pandemic challenges.
October 14, 2020
Universal strategy push elicits range of constituency views.
September 11, 2020
Orphan drug incentives set to remain in place in Europe.
August 25, 2020
Christine Phillips looks at how an increase in protectionism across the EU member states with respect to foreign direct investment impacts the life sciences sector.
August 07, 2020
Budget battle threatens efforts to bolster Europe’s pharma strategy.
August 02, 2020
Andrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
